Terje Arnulf Johansen • 1955 • Silsand • 16 roles • 25 shareholdings

Roles

Name	Role	Total operating income	Total equity	Shares
L LYR INVEST AS	Managing Director/CEO	-	180,209,677	90.1 % directly
F FDV TROMS AS	Managing Director/CEO	7,009,704	12,104,957	63.07 % indirectly
T TAJ EIENDOM AS	Managing Director/CEO	-	-1,453,081	63.07 % indirectly
B BOLIGUTVIKLING SØR AS	Managing Director/CEO	1,148,000	-1,999,543	63.07 % indirectly
T TAJ HOLDING AS	Managing Director/CEO	75,072,912	179,647,693	63.07 % indirectly
A ARELIA AS	Managing Director/CEO	-	37,287	50.46 % indirectly
A ANS BYGG I NORD	Managing Director/CEO	-	-	-

Name	Role	Total operating income	Total equity	Shares
L LYR INVEST AS	Chairman	-	180,209,677	90.1 % directly
C CAMPUS NORGE AS	Chairman	1,845,404	-1,312,215	63.07 % indirectly
F FDV TROMS AS	Chairman	7,009,704	12,104,957	63.07 % indirectly
T TAJ EIENDOM AS	Chairman	-	-1,453,081	63.07 % indirectly
B BOLIGUTVIKLING SØR AS	Chairman	1,148,000	-1,999,543	63.07 % indirectly
T TAJ HOLDING AS	Chairman	75,072,912	179,647,693	63.07 % indirectly
T TJ EIENDOM AS	Chairman	-	12,422,123	59.92 % indirectly
A ARELIA AS	Chairman	-	37,287	50.46 % indirectly
A ANS BYGG I NORD	Participant with Joint and Several Liability (Full Responsibility)	-	-	-

Last update: Dec 16, 2023

Name	Share class	Total operating income	Total equity	Share
L LYR INVEST AS	Ordinære aksjer	0	180,209,677	90.1 % directly
C CAMPUS NORGE AS		1,845,404	-1,312,215	63.07 % indirectly
F FDV TROMS AS		7,009,704	12,104,957	63.07 % indirectly
T TAJ EIENDOM AS		0	-1,453,081	63.07 % indirectly
B BOLIGUTVIKLING SØR AS		1,148,000	-1,999,543	63.07 % indirectly
T TAJ HOLDING AS		75,072,912	179,647,693	63.07 % indirectly
T TJ EIENDOM AS		0	12,422,123	59.92 % indirectly
A ARELIA AS		0	37,287	50.46 % indirectly
N NORSK EIENDOM OG UTVIKLING AS		8,980,000	2,006,617	26.49 % indirectly
A AMICOAT AS		17,688,664	55,955,218	8.54 % indirectly
P PEPTIDE PATENTS AS		1,081,801	654,242	8.27 % indirectly
P PHARMA HOLDINGS AS		1,740,889	16,353,280	8.01 % indirectly
L LYTIX BIOPHARMA AS		3,991,213	51,319,307	6.87 % indirectly
L LYSAKER PARK INVEST I AS		356,604	9,716,304	5.36 % indirectly
L LYSAKER PARK INVEST II AS		0	152,468,744	4.46 % indirectly
O OBSERVE MEDICAL ASA		2,591,000	355,305,000	1.25 % indirectly
O OBSERVE MEDICAL AS		0	-440,466	1.25 % indirectly
B BIIM ULTRASOUND AS		4,069,953	-29,193,114	1.24 % indirectly
N NORTH ENERGY ASA		72,000	368,737,000	1.01 % indirectly
N NORTH INDUSTRIES 2 AS		0	68,327,565	1.01 % indirectly
N NORTH INDUSTRIES 1 AS		0	179,876,205	1.01 % indirectly
P PHARMASUM THERAPEUTICS AS		1,379,500	2,785,322	0.92 % indirectly
T TYVEHOLMEN AS		6,012,003	8,148,938	0.5 % indirectly
P PGS ASA	NO0010199151	0	6,420,000,000	0.1 % directly < 0.01 %
A AKER ASA	NO0010234552	0	23,669,000,000	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024